Male-to-female transmission of human T-cell lymphotropic virus types I and II: Association with viral load

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 2, 1996, Pages 193-201

  Kaplan, Jonathan E ^a,h   Khabbaz, Rima F ^a   Murphy, Edward L ^b   Hermansen, Sigurd ^c   Roberts, Chester ^d   Lal, Renu ^a   Heneine, Walid ^a   Wright, David ^c   Matijas, Lauri ^c   Thomson, Ruth ^c   Rudolph, Donna ^a   Switzer, William M ^a   Kleinman, Steven ^e,f   Busch, Michael ^b,g   Schreiber, George B ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WESTAT   (United States)

^d SRA Technologies Inc   (United States)

^e AMERICAN RED CROSS BLOOD SERVICES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Blood Centers of the Pacific   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HTLV; HTLV I; HTLV II; Human T lymphotropic virus; Sexual transmission; Viral load

Indexed keywords

ARTICLE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; T LYMPHOCYTE; VIREMIA; VIRUS DETECTION; VIRUS TRANSMISSION;

HTLV; HTLV I; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 1542744621     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199606010-00014     Document Type: Article

References (38)

1. Kaplan JE, Khabbaz RF. The epidemiology of human T-lymphotropic virus types I and II. Rev Med Virol 1993;3:137-48.
2. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurode-generative disease associated with HTLV-II infection. Lancet 1992;339:645-6.
3. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993;33:392-6.
4. Harrington WJ, Sheremata W, Hjelle B, et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411-414.
5. Murphy EL, Engstrom JW, Miller K, et al.-HTLV-II associated myelopathy in a 43-year-old woman. Lancet 1993;341:757-8.
6. Centers for Disease Control. Licensure of screening tests for antibody to human T-lymphotropic virus type I. MMWR 1988;37:736-40,745-7.
7. Centers for Disease Control. Human T-lymphotropic virus type I screening in volunteer blood donors-United States, 1989. MMWR 1990;39:915,921-4.
8. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 1986;154:851-7.
9. Murphy EL, Figueroa JP, Gibbs WN, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989;111:555-60.
10. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T-cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki cohort study. J Infect Dis 1993;167:57-65.
11. Vitek CR, Gracia FI, Giusti R, et al. Evidence for sexual and mother-to-child transmission of human T-lymphotropic virus type II among Guaymi Indians, Panama. J Infect Dis 1995;171:1022-6.
12. Hjelle B, Cyrus S, Swenson SG. Evidence for sexual transmission of human T-lymphotropic virus type II. Ann Intern Med 1992;116:90-1.
13. Chen Y-MA, Okayama A, Lee T-H, Tachibana N, Mueller N, Essex M. Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-fax antibody. Proc Natl Acad Sci USA 1991;88:1182-6.
14. Ho GYF, Nomura AMY, Nelson K, Lee H, Polk BF, Blattner WA. Declining seroprevalence and transmission of HTLV-I in Japanese families who immigrated to Hawaii. Am J Epidemiol 1991;134:981-7.
15. Schwebke J, Calsyn D, Shriver K, et al. Prevalence and epidemiologic correlates of human T-cell lymphotropic virus infection among intravenous drag users. J Infect Dis 1994;169:962-7.
16. Kleinman SH, Kaplan JE, Khabbaz RF, et al. Evaluation of a p21e-spiked Western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. J Clin Microbiol 1994;32:603-7.
17. Busch MP, Laycock M, Kleinman SH, et al. Accuracy of supplemental serologic testing for human T-lymphotropic virus type I and II in United States blood donors. Blood 1994;83:1143-8.
18. Lal RB, Rudolph DL, Griffis KP, et al. Characterization of immunodominant epitopes of gag and pol gene encoded proteins of human T-lymphotropic virus type-I. 7 Virol 1991;65:1870-6.
19. Rudolph DL, Lal RB. Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides comprising structural epitopes from the envelope glycoproteins. Clin Chem 1993;39:288-92.
20. tax) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay. Clin Diag Lab Immunol 1994;1:176-81.
21. Buckner C, Roberts CR, Foung SKH, et al. Immune responsiveness to the immunodominant envelope epitopes of HTLV-I and HTLV-II in diverse geographic populations. J Infect Dis 1992;166:1160-3.
22. Hino S, Katamine S, Miyamoto T, et al. Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of HTLV-I: maternal anti-env antibodies correlate with protection in non-breast-fed children. J Clin Invest 1995;95:2920-5.
23. Hartley TM, Malone GE, Khabbaz RF, Lal RB, Kaplan JE. Evaluation of recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary-test in HTLV-I/II antibody testing algorithms. J Clin Microbiol 1991 ;29:1125-7.
24. Switzer WM, Pieniazek D, Swanson P, et al. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995;69:621-32.
25. Vidal AU, Gessain A, Mitsuyaki Y, et al. Phylogenetic classification of human T cell leukemia/lymphoma virus type 1 genotypes in five major molecular and geographical sub-types. J Gen Virol 1994;75:3655-66.
26. Wood R, Dong H, Katzenstein DA, Merigan TC. Quantification and comparison of HIV-1 pro viral load in peripheral blood mononuclear cells and isolated CD4+ cells. J Acquir Immune Defic Syndr 1993;6:237-40.
27. Snedecor GW, Cochran WG, eds. Statistical methods, 7th ed. Ames, IA: Iowa State University Press, 1980.
28. Homer DW, Lameshow S, eds. Applied logistic regression. New York: John Wiley & Sons, 1989.
29. Yoshinaga M, Yashiki S, Oki T, Fujiyoshi T, Nagata Y, Sonoda S. A maternal risk factor for mother-to-child HTLV-I transmission: viral antigen-producing capacities in culture of peripheral blood and breast milk cells. Jpn J Cancer Res 1995;86:649-54.
30. Matsumura M, Kushida S, Ami Y, et al. Quantitaten of HTLV-I provirus among seropositive blood donors: relation with antibody profile using synthetic peptides. Int J Cancer 1993;55:220-2.
31. Shinzato O, Kamihara S, Ikeda S, et al. Relationship between the anti-HTLV-I antibody level, the number of abnormal lymphocytes, and the viral-genome dose in HTLV-I-infected individuals. Int J Cancer 1993;54:208-12.
32. Weiser B, Nachman S, Tropper P, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 1994;91:8037-41.
33. Busch MP (Transfusion Safety Study). Clinical and virological factors influencing transmission of HIV-1 by transfusion [Abstract]. Transfusion 1992;32(8S):56S.
34. Clerici M, Clark EA, Polacino P, et al. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994;8:1391-5.
35. Cardo D, Srivasztava P, Ciesielski C, et al. Case-control study of HIV seroconversion in health care workers (HCWs) after percutaneous exposure (PE) to HIV-infected blood. Abstract No. 1236. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1994.
36. O'Brien TR, Busch MP, Donegan E, et al. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr 1994;7:705-10.
37. Ishihara S, Okayama A, Stuver S, et al. Association of HTLV-1 antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J Acquir Immune Defic Syndr 1994;7:199-203.
38. Centers for Disease Control and U.S.P.H.S. Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med 1993;118:448-54.